HCW Biologics Inc. Common Stock earnings per share and revenue
On Nov 14, 2025, HCWB reported earnings of -2.02 USD per share (EPS) for Q3 25, beating the estimate of -2.34 USD, resulting in a 13.90% surprise. Revenue reached 426.00 thousand, compared to an expected 7.14 million, with a -94.03% difference. The market reacted with a +2.00% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were HCW Biologics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, HCW Biologics Inc. Common Stock reported EPS of -$2.02, beating estimates by 13.9%, and revenue of $426.00K, -94.03% below expectations.
How did the market react to HCW Biologics Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 2%, changed from $3.00 before the earnings release to $3.06 the day after.
When is HCW Biologics Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for HCW Biologics Inc. Common Stock's next earnings report?
Based on --
analysts, HCW Biologics Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.